参天製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/25 | 1,318 | 1,335 | 1,305 | 1,334 | +7 | +0.5% | 1,054,600 |
| 2022/01/24 | 1,284 | 1,327 | 1,283 | 1,327 | +38 | +2.9% | 1,474,000 |
| 2022/01/21 | 1,299 | 1,300 | 1,275 | 1,289 | -16 | -1.2% | 1,901,100 |
| 2022/01/20 | 1,301 | 1,320 | 1,300 | 1,305 | +4 | +0.3% | 1,595,500 |
| 2022/01/19 | 1,330 | 1,338 | 1,298 | 1,301 | -42 | -3.1% | 1,486,900 |
| 2022/01/18 | 1,380 | 1,383 | 1,340 | 1,343 | -37 | -2.7% | 1,530,700 |
| 2022/01/17 | 1,389 | 1,395 | 1,370 | 1,380 | -6 | -0.4% | 670,200 |
| 2022/01/14 | 1,403 | 1,414 | 1,378 | 1,386 | -46 | -3.2% | 1,602,200 |
| 2022/01/13 | 1,460 | 1,463 | 1,431 | 1,432 | -7 | -0.5% | 1,270,100 |
| 2022/01/12 | 1,437 | 1,457 | 1,435 | 1,439 | +12 | +0.8% | 1,396,200 |
| 2022/01/11 | 1,423 | 1,432 | 1,408 | 1,427 | +18 | +1.3% | 1,158,200 |
| 2022/01/07 | 1,417 | 1,425 | 1,401 | 1,409 | -6 | -0.4% | 854,800 |
| 2022/01/06 | 1,410 | 1,432 | 1,409 | 1,415 | -7 | -0.5% | 919,800 |
| 2022/01/05 | 1,421 | 1,431 | 1,416 | 1,422 | -10 | -0.7% | 1,074,600 |
| 2022/01/04 | 1,417 | 1,439 | 1,412 | 1,432 | +25 | +1.8% | 788,400 |
| 2021/12/30 | 1,410 | 1,416 | 1,403 | 1,407 | -10 | -0.7% | 733,400 |
| 2021/12/29 | 1,421 | 1,437 | 1,413 | 1,417 | -2 | -0.1% | 767,500 |
| 2021/12/28 | 1,406 | 1,420 | 1,402 | 1,419 | +17 | +1.2% | 675,000 |
| 2021/12/27 | 1,404 | 1,406 | 1,398 | 1,402 | -10 | -0.7% | 497,900 |
| 2021/12/24 | 1,418 | 1,418 | 1,405 | 1,412 | ±0 | ±0% | 623,900 |
| 2021/12/23 | 1,420 | 1,420 | 1,405 | 1,412 | +1 | +0.1% | 693,600 |
| 2021/12/22 | 1,415 | 1,419 | 1,405 | 1,411 | +3 | +0.2% | 1,191,100 |
| 2021/12/21 | 1,405 | 1,420 | 1,399 | 1,408 | +17 | +1.2% | 1,399,900 |
| 2021/12/20 | 1,388 | 1,397 | 1,383 | 1,391 | -7 | -0.5% | 1,228,800 |
| 2021/12/17 | 1,417 | 1,427 | 1,391 | 1,398 | -13 | -0.9% | 1,986,800 |
| 2021/12/16 | 1,427 | 1,430 | 1,404 | 1,411 | +9 | +0.6% | 1,341,500 |
| 2021/12/15 | 1,398 | 1,418 | 1,398 | 1,402 | -10 | -0.7% | 1,347,300 |
| 2021/12/14 | 1,395 | 1,415 | 1,395 | 1,412 | +14 | +1% | 1,286,300 |
| 2021/12/13 | 1,412 | 1,414 | 1,398 | 1,398 | -14 | -1% | 1,209,600 |
| 2021/12/10 | 1,420 | 1,427 | 1,405 | 1,412 | -22 | -1.5% | 1,502,600 |
| 2021/12/09 | 1,437 | 1,446 | 1,434 | 1,434 | -21 | -1.4% | 1,153,100 |
| 2021/12/08 | 1,451 | 1,466 | 1,445 | 1,455 | +22 | +1.5% | 1,462,400 |
| 2021/12/07 | 1,425 | 1,433 | 1,409 | 1,433 | +8 | +0.6% | 1,980,200 |
| 2021/12/06 | 1,430 | 1,436 | 1,407 | 1,425 | -8 | -0.6% | 1,205,400 |
| 2021/12/03 | 1,400 | 1,434 | 1,400 | 1,433 | +23 | +1.6% | 1,430,000 |
| 2021/12/02 | 1,427 | 1,431 | 1,404 | 1,410 | -47 | -3.2% | 2,080,200 |
| 2021/12/01 | 1,481 | 1,482 | 1,450 | 1,457 | -47 | -3.1% | 1,575,900 |
| 2021/11/30 | 1,530 | 1,550 | 1,502 | 1,504 | -7 | -0.5% | 2,650,400 |
| 2021/11/29 | 1,533 | 1,541 | 1,508 | 1,511 | -43 | -2.8% | 864,600 |
| 2021/11/26 | 1,577 | 1,578 | 1,541 | 1,554 | -36 | -2.3% | 829,800 |
| 2021/11/25 | 1,567 | 1,597 | 1,560 | 1,590 | +23 | +1.5% | 660,400 |
| 2021/11/24 | 1,559 | 1,576 | 1,551 | 1,567 | -2 | -0.1% | 812,400 |
| 2021/11/22 | 1,542 | 1,576 | 1,534 | 1,569 | +14 | +0.9% | 869,600 |
| 2021/11/19 | 1,565 | 1,572 | 1,540 | 1,555 | -5 | -0.3% | 1,112,500 |
| 2021/11/18 | 1,566 | 1,571 | 1,535 | 1,560 | -8 | -0.5% | 875,200 |
| 2021/11/17 | 1,591 | 1,594 | 1,556 | 1,568 | -17 | -1.1% | 872,500 |
| 2021/11/16 | 1,589 | 1,592 | 1,576 | 1,585 | -5 | -0.3% | 558,700 |
| 2021/11/15 | 1,567 | 1,593 | 1,567 | 1,590 | +12 | +0.8% | 668,800 |
| 2021/11/12 | 1,573 | 1,595 | 1,571 | 1,578 | +13 | +0.8% | 565,300 |
| 2021/11/11 | 1,540 | 1,578 | 1,537 | 1,565 | +17 | +1.1% | 713,300 |
801～
850
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
| ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
